Clover Biopharmaceuticals
Executivos
Veja o organograma con seus 24 executivos principais
Biografias mais buscadas da Clover Biopharmaceuticals
- Joshua Liang, Chief Executive Officer
- Xiang Liao, Independent Non-executive Director
- Donna Ambrosino, Director
Criar um alerta
para seguir os movimentos de executivos da Clover Biopharmaceuticals.
Farmacêutica
Clover Biopharmaceuticals possui 1.861 concorrentes concorrentes Pfizer (Estados Unidos), Sanofi (França) e Johnson & Johnson (Estados Unidos).
Popular M&A news in Farmacêutica
- MedMen has filed for bankruptcy protection (publicado em 28 de abril de 2024).
- AstraZeneca has announced the acquisition of Fusion Pharma (publicado em 23 de março de 2024).
- AstraZeneca has announced the acquisition of Amolyt Pharma (publicado em 19 de março de 2024).
Outros contatos sugeridos na indústria do Farmacêutica
Notícias
Últimos comunicados de imprensa de Clover Biopharmaceuticals
- Clover’s COVID-19 Vaccine Candidate Demonstrates Strong Cross-Neutralization Against Omicron as a Homologous Booster | Clover Biopharmaceuticals, Ltd.
- Clover Doses First Participants in Phase 3 Trial Evaluating SCB-2019 as a Heterologous COVID-19 Booster Following Prior Vaccination with Inactivated, mRNA or Viral Vector Vaccines | Clover Biopharmaceuticals, Ltd.
- Clover Provides Update on 2022 Corporate Milestones | Clover Biopharmaceuticals, Ltd.
- Clover Doses First Participants in Phase 1 Trial with SCB-2020S, a Potentially Broadly Protective Chimeric COVID-19 Vaccine Candidate | Clover Biopharmaceuticals, Ltd.
- Clover’s Bivalent COVID-19 Vaccine Candidate Demonstrates Broad Neutralization Against Omicron and Other Variants of Concern | Clover Biopharmaceuticals, Ltd.
- Clover Appoints LiongHo Chua as President of Greater China | Clover Biopharmaceuticals, Ltd.
- Clover’s COVID-19 Vaccine Candidate Administered as Heterologous Booster in Investigator-Led Phase 2 Clinical Trial - Clover Biopharmaceuticals
- Clover and CEPI Expand Partnership for COVID-19 Vaccine Candidate to Include Evaluation as a Booster - Clover Biopharmaceuticals
- Clover Biopharmaceuticals Announces Offer Price and Allotment Results of the Global Offering - Clover Biopharmaceuticals
- Clover Biopharmaceuticals Completes Enrollment of Adult and Elderly Population in SPECTRA Global Phase 2/3 Clinical Trial for its COVID-19 Vaccine Candidate - Clover Biopharmaceuticals
- View more press releases Close
Redes sociais sobre Clover Biopharmaceuticals
- Clover Biopharmaceuticals na Wikipedia, Google News e Yahoo Finance
- Clover Biopharmaceuticals na LinkedIn, Twitter e YouTube
Entrar em contato
Contate seus executivos por e-mail agora, incluindo Joshua Liang 
Ligue para a Clover Biopharmaceuticals em +86 288...
